Discontinued — last reported Q2 '25
International Flavors & Fragrances Pharma Solutions — Net Sales decreased by 61.3% to $103.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 62.3%, from $273.00M to $103.00M. Over 3 years (FY 2021 to FY 2024), Pharma Solutions — Net Sales shows an upward trend with a 9.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher demand for pharmaceutical ingredients, while a decrease may signal competitive pressure or product lifecycle maturity.
Represents the total revenue generated from the sale of pharmaceutical ingredients and specialty solutions within the Ph...
Commonly reported as Segment Revenue or Net Sales by specialty chemical and pharmaceutical ingredient peers.
iff_segment_pharma_solutions_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $232.00M | $211.00M | $204.00M | $249.00M | $244.00M | $257.00M | $221.00M | $253.00M | $251.00M | $238.00M | $278.00M | $250.00M | $273.00M | $278.00M | $248.00M | $266.00M | $103.00M |
| QoQ Change | — | -9.1% | -3.3% | +22.1% | -2.0% | +5.3% | -14.0% | +14.5% | -0.8% | -5.2% | +16.8% | -10.1% | +9.2% | +1.8% | -10.8% | +7.3% | -61.3% |
| YoY Change | — | — | — | — | +5.2% | +21.8% | +8.3% | +1.6% | +2.9% | -7.4% | +25.8% | -1.2% | +8.8% | +16.8% | -10.8% | +6.4% | -62.3% |